Fig. 1From: Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccineTrial Schema. Trial schema with schedules of vaccine administrations, immune analysis, and clinical staging evaluations, indicatedBack to article page